How should an atheromatous aorta be managed?

Management of Atheromatous Aorta

In patients with atheromatous aortic plaques, single antiplatelet therapy (SAPT) with intensive lipid management targeting LDL-C <55 mg/dL (<1.4 mmol/L) is recommended, while anticoagulation and dual antiplatelet therapy should be avoided due to increased bleeding risk without benefit 1.

Primary vs. Secondary Prevention Strategy

The management approach differs critically based on whether the patient has experienced an embolic event:

For Patients WITH Prior Embolic Events (Secondary Prevention)

Medical therapy is the cornerstone:

• Initiate intensive statin therapy targeting LDL-C <55 mg/dL (<1.4 mmol/L) to prevent recurrent embolic events 111
• Start single antiplatelet therapy (aspirin or clopidogrel) 111
• Avoid anticoagulation and dual antiplatelet therapy - these provide no benefit and significantly increase bleeding risk 111

For Asymptomatic Atheromatous Plaques (Primary Prevention)

• Focus on aggressive cardiovascular risk factor modification
• Statin therapy per standard atherosclerotic cardiovascular disease guidelines
• Single antiplatelet therapy may be considered based on overall cardiovascular risk
• No routine revascularization or intervention 1

Surgical Considerations

Surgical resection is reserved for highly selected cases:

• Large, mobile atheromas with documented embolic events despite medical therapy 2
• Patients undergoing cardiac surgery where the atheroma poses high perioperative embolic risk 345

The 2024 ESC guidelines explicitly state that routine intervention for asymptomatic atherosclerotic lesions is not recommended 1. However, when mobile ascending aortic atheromas present with systemic embolization, surgical resection with multimodal imaging guidance becomes necessary 2.

Imaging and Surveillance

Transesophageal echocardiography (TEE) is the gold standard for detecting and characterizing aortic atheromas, particularly in the ascending aorta and arch 245. When aortic atheroma is identified:

• Assess the entire aorta at baseline 11
• Use CT angiography or MRI for comprehensive evaluation of plaque burden and distribution 6
• Epiaortic scanning during cardiac surgery provides the most accurate intraoperative assessment 45

Critical Pitfalls to Avoid

Do not anticoagulate isolated aortic atheromas - this is a Class III recommendation (harm) in the 2024 ESC guidelines due to increased bleeding without embolic benefit 111. This represents a common error where clinicians mistakenly treat aortic atheroma like cardiac thrombus.

Do not use dual antiplatelet therapy for the same reason - no benefit, increased bleeding 1.

Perioperative Management

For patients with extensive atheromatous disease requiring cardiac surgery 34:

• Perform detailed 3D CT preoperative planning to identify graftable sites
• Consider alternative cannulation strategies (axillary or femoral) to avoid diseased ascending aorta
• Use epiaortic scanning to guide clamp placement
• Consider off-pump techniques or complete avoidance of aortic manipulation when feasible
• In severe cases, consider ascending aorta replacement under deep hypothermic circulatory arrest

Risk Factor Management

Beyond lipid and antiplatelet therapy, address:

• Smoking cessation (critical for preventing progression)
• Blood pressure control targeting systolic <130 mmHg
• Diabetes management
• Annual follow-up to assess cardiovascular risk factors and treatment adherence 11

The evidence strongly supports that medical management with intensive lipid lowering and single antiplatelet therapy is the primary strategy, with surgical intervention reserved only for high-risk mobile lesions causing recurrent embolization despite optimal medical therapy 12.